Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

GLIMSTAR M 1.0mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Mankind Pharma Ltd

Salt Composition

Glimepiride (1.0mg) + Metformin (500mg)

Overview GLIMSTAR M 1.0mg/500mg Tablet

Diabetic patients using GLIMSTAR M 1.0mg/500mg tablets, an antidiabetic medication combining two active agents, should adhere to prescribed dosages. This dual-action formulation manages blood glucose in adult type 2 diabetics. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage adjustments are determined by your physician based on your blood glucose response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications like nephropathy, retinopathy, neuropathy, and limb loss. A holistic approach, encompassing diet, exercise, and weight management under medical supervision, is essential for effective diabetes control. Hypoglycemia (low blood sugar) is a frequent adverse effect, characterized by sweating, dizziness, headache, and tremors. Carry readily available glucose sources, such as sweets or juice, to counter this. Alcohol consumption should be minimized due to its hypoglycemic potential. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals must consult their doctor before using GLIMSTAR M. Regular blood glucose monitoring, along with blood cell and liver function tests as recommended by your physician, is necessary.

Uses of GLIMSTAR M 1.0mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of GLIMSTAR M 1.0mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the GLIMSTAR M 1.0mg/500mg Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

Common Side effects of GLIMSTAR M 1.0mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use GLIMSTAR M 1.0mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the GLIMSTAR M 1.0mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How GLIMSTAR M 1.0mg/500mg Tablet works:

GLIMSTAR M tablets (1.0mg glimepiride/500mg metformin) combine two anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking GLIMSTAR M 1.0mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using GLIMSTAR M 1.0mg/500mg tablets during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Maternal use of GLIMSTAR M 1.0mg/500mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use GLIMSTAR M 1.0mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. In cases of severe kidney disease, GLIMSTAR M 1.0mg/500mg tablets are contraindicated. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use GLIMSTAR M 1.0mg/500mg tablets cautiously, potentially requiring dose modification. Consult a physician for guidance. Low initial doses are typically recommended for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take GLIMSTAR M 1.0mg/500mg Tablet :

Should you forget to take your GLIMSTAR M 1.0mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About GLIMSTAR M 1.0mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on GLIMSTAR M 1.0mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
GLIMSTAR M 1.0mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue GLIMSTAR M 1.0mg/500mg Tablets and seek immediate medical attention.
GLIMSTAR M 1.0mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
GLIMSTAR M 1.0mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of GLIMSTAR M 1.0mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
GLIMSTAR M 1.0mg/500mg Tablets can cause low blood sugar (hypoglycemia), leading to symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining GLIMSTAR M 1.0mg/500mg Tablets with alcohol is unsafe. This combination can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
GLIMSTAR M 1.0mg/500mg Ta...
66
MRP 80
17% off